Skip to content

What Happens in Vegas: PEP to PrEP Opportunities

What Happens in Vegas: Identifying Opportunities to Expand an HIV Prevention Network to Improve PEP and PrEP Delivery

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03775083
Enrollment
75
Registered
2018-12-13
Start date
2018-09-01
Completion date
2019-08-31
Last updated
2018-12-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Exposure to Human Immunodeficiency Virus (Event)

Keywords

PEP, nPEP, Post Exposure Prophylaxis, non occupational exposure to HIV

Brief summary

Observational study looking at barriers to care for individuals seeking care, Post Exposure Prophylaxis (PEP) after an actual or perceived exposure to HIV. Following PEP treatment subjects will be asked about there intent to transition to Pre-Exposure Prophylaxis (PrEP) and surveyed about barriers to care or perceptions of care

Detailed description

The primary objective of this study is to assess the rate of engagement in a PEP to PrEP HIV provider network for those patients presenting following a non-occupational HIV exposure. The development of a referral network and intensive clinical follow up of PEP patients will result in more patients appropriately initiating PEP, being referred to appropriate follow up, and post exposure transition and maintaining on PrEP (if indicated) at completion of the PEP medications.

Interventions

DRUGCurrently approved medications

subjects will be treated according to current Department of Health and Human Services (DHHS) Center for Disease control and prevention (CDC), Society for Healthcare Epidemiology of American (SHEA guidelines for nPEP

Sponsors

Huntridge Family Clinic
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Actual or perceived non-occupational exposure to HIV, by self report, within 72 hours of enrollment and referred for care * able and willing to provide informed consent * available for 12 months of post expoure follow-up Southern Nevada Ryan White defined service area

Exclusion criteria

* HIV+ at time of screeing via 4th genderation (Antibody/Antigen) testing * Current PEP and/or PrEP product condrainidications as listed in the medication product insert.

Design outcomes

Primary

MeasureTime frameDescription
rate of engagementfrom enrollment to day 90Assess the rate of engagement in a PEP to PrEP HIV prevention provider network for those patients presenting following a non-occupational HIV exposure

Secondary

MeasureTime frameDescription
characteristicsfrom enrollment through end of study for all participantsDescribe the characteristics of patients successfully engaging in HIV prevention via a patient collected survey using a qualtric survey.
barriersfrom enrollment through end of study for all participantsIdentify and assess barriers to access to HIV prevention care including PEP in the period immediately following HIV exposure from a patient collected survey using a qualtric survey tool
Network characteristicsfrom enrollment through end of study for all participantsAnalyze the network characteristics that faciliate engagement in HIV prevention services from a patient collected survey using a qualtric survey tool
transition barriersfrom enrollment through end of study for all participantsDetermine and assess to transitioning from PEP to PrEP from a patient collected survey using a qualtric survey tool
Retentionfrom enrollment through end of study for all participantsCompare and contrast the barriers to access and ongoing retention to PrEP from a patient collected survey using a qualtric survey tool.

Countries

United States

Contacts

Primary ContactJohn (Rob) Phoenix, MSN, APRN
jphoenixaprn@gmail.com702-979-1111
Backup ContactChristina Madison, PharmD
cmadison@roseman.edu702-968-2044

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026